Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.14 - $0.21 $24,283 - $36,425
173,455 Added 11.0%
1,750,573 $245,000
Q3 2022

Nov 10, 2022

BUY
$0.14 - $1.83 $17,753 - $232,065
126,812 Added 8.74%
1,577,118 $224,000
Q2 2022

Aug 12, 2022

BUY
$1.34 - $2.08 $208,190 - $323,161
155,366 Added 12.0%
1,450,306 $2.34 Million
Q1 2022

May 16, 2022

BUY
$1.1 - $2.17 $508,930 - $1 Million
462,664 Added 55.59%
1,294,940 $1.96 Million
Q4 2021

Feb 14, 2022

SELL
$1.99 - $3.1 $88,568 - $137,971
-44,507 Reduced 5.08%
832,276 $1.66 Million
Q3 2021

Nov 12, 2021

BUY
$2.47 - $3.34 $79,291 - $107,220
32,102 Added 3.8%
876,783 $2.73 Million
Q2 2021

Aug 16, 2021

BUY
$2.56 - $3.35 $102,246 - $133,799
39,940 Added 4.96%
844,681 $2.56 Million
Q1 2021

May 14, 2021

BUY
$2.01 - $5.05 $418,435 - $1.05 Million
208,177 Added 34.9%
804,741 $2.62 Million
Q4 2020

Feb 12, 2021

BUY
$1.89 - $2.55 $16,157 - $21,799
8,549 Added 1.45%
596,564 $1.24 Million
Q3 2020

Nov 13, 2020

BUY
$2.46 - $6.15 $80,946 - $202,365
32,905 Added 5.93%
588,015 $1.46 Million
Q2 2020

Aug 12, 2020

BUY
$2.01 - $5.95 $338,843 - $1 Million
168,579 Added 43.61%
555,110 $3.27 Million
Q1 2020

May 13, 2020

BUY
$1.87 - $4.47 $77,221 - $184,588
41,295 Added 11.96%
386,531 $931,000
Q4 2019

Feb 12, 2020

BUY
$2.48 - $8.1 $23,919 - $78,124
9,645 Added 2.87%
345,236 $1.32 Million
Q3 2019

Nov 12, 2019

BUY
$8.22 - $11.2 $71,809 - $97,843
8,736 Added 2.67%
335,591 $2.8 Million
Q2 2019

Aug 14, 2019

BUY
$10.05 - $14.25 $133,443 - $189,211
13,278 Added 4.23%
326,855 $3.7 Million
Q1 2019

May 14, 2019

SELL
$11.82 - $14.48 $196,389 - $240,585
-16,615 Reduced 5.03%
313,577 $4.01 Million
Q4 2018

Feb 13, 2019

BUY
$10.8 - $17.94 $473,914 - $787,225
43,881 Added 15.33%
330,192 $4.18 Million
Q3 2018

Nov 13, 2018

BUY
$10.92 - $18.18 $3.13 Million - $5.21 Million
286,311 New
286,311 $5.16 Million
Q1 2018

May 15, 2018

SELL
$9.36 - $15.22 $237,163 - $385,644
-25,338 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$8.48 - $12.0 $214,866 - $304,056
25,338
25,338 $247,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.